AU2006315348A1 - Method to assess breast cancer risk - Google Patents

Method to assess breast cancer risk Download PDF

Info

Publication number
AU2006315348A1
AU2006315348A1 AU2006315348A AU2006315348A AU2006315348A1 AU 2006315348 A1 AU2006315348 A1 AU 2006315348A1 AU 2006315348 A AU2006315348 A AU 2006315348A AU 2006315348 A AU2006315348 A AU 2006315348A AU 2006315348 A1 AU2006315348 A1 AU 2006315348A1
Authority
AU
Australia
Prior art keywords
breast cancer
adam
subject
risk
mmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006315348A
Other languages
English (en)
Inventor
Marsha A. Moses
Susan Pories
David Zurakowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Beth Israel Deaconess Medical Center Inc
Original Assignee
Boston Childrens Hospital
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital, Beth Israel Deaconess Medical Center Inc filed Critical Boston Childrens Hospital
Publication of AU2006315348A1 publication Critical patent/AU2006315348A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2006315348A 2005-11-16 2006-11-16 Method to assess breast cancer risk Abandoned AU2006315348A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73728105P 2005-11-16 2005-11-16
US60/737,281 2005-11-16
US84645606P 2006-09-22 2006-09-22
US60/846,456 2006-09-22
PCT/US2006/044684 WO2007059313A1 (en) 2005-11-16 2006-11-16 Method to assess breast cancer risk

Publications (1)

Publication Number Publication Date
AU2006315348A1 true AU2006315348A1 (en) 2007-05-24

Family

ID=37846993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006315348A Abandoned AU2006315348A1 (en) 2005-11-16 2006-11-16 Method to assess breast cancer risk

Country Status (6)

Country Link
US (1) US20090215102A1 (enExample)
EP (1) EP1938105A1 (enExample)
JP (1) JP2009515556A (enExample)
AU (1) AU2006315348A1 (enExample)
CA (1) CA2629793A1 (enExample)
WO (1) WO2007059313A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2009059284A2 (en) 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
WO2009158620A2 (en) * 2008-06-26 2009-12-30 Dana-Farber Cancer Institute, Inc. Signatures and determinants associated with metastasis methods of use thereof
CN101738478A (zh) * 2008-11-27 2010-06-16 浙江大学 Mmp9作为卵巢癌的诊断标记物的用途
ES2458818T3 (es) * 2009-04-16 2014-05-07 Momenta Pharmaceuticals, Inc. Métodos para evaluar la actividad de una composición de polisacárido
EP2558598A4 (en) * 2010-04-13 2013-12-04 Univ Columbia BIOMARKER BASED ON A MECHANISM ASSOCIATED WITH A MULTI-CARCINOMA INVASION
CN102985443B (zh) 2010-04-16 2017-05-10 动量制药公司 组织靶向
US10017585B2 (en) 2010-06-17 2018-07-10 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
RU2586295C2 (ru) * 2010-06-18 2016-06-10 Б.Р.А.Х.М.С Гмбх Биомаркеры для прогнозирования возникновения рака
EP2943585B1 (en) 2013-01-09 2018-07-11 Friedrich-Alexander-Universität Erlangen-Nürnberg Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
EP3003324A4 (en) 2013-05-28 2017-01-25 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
US10613090B2 (en) 2014-05-09 2020-04-07 Ascendant Diagnostics, LLC Methods of detecting cancer
US12320811B2 (en) 2014-05-09 2025-06-03 Ascendant Diagnostics, LLC Methods of detecting cancer
JP2020506405A (ja) * 2017-02-08 2020-02-27 シルバイオテック・インコーポレイテッド 乳がんリスクを判定する方法
WO2019032744A1 (en) * 2017-08-11 2019-02-14 Panacea Pharmaceticals Inc. HAAH AND MMP-9 AS COMPLEMENTARY CANCER BIOMARKERS AND METASTASE PREDICTORS WHEN COMBINING THEM
CN114664435A (zh) * 2022-03-28 2022-06-24 上海交通大学医学院附属瑞金医院 先天性肾上腺皮质增生症诊断模型及其构建方法和应用
WO2024086792A2 (en) * 2022-10-21 2024-04-25 The Trustees Of Indiana University Methods for promoting homing and engraftment of hematopoietic stem cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
AU2005207318B2 (en) * 2004-01-09 2012-02-02 Children's Medical Center Corporation Methods for diagnosis and prognosis of cancers of epithelial origin

Also Published As

Publication number Publication date
JP2009515556A (ja) 2009-04-16
US20090215102A1 (en) 2009-08-27
EP1938105A1 (en) 2008-07-02
WO2007059313A1 (en) 2007-05-24
CA2629793A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
US20190361028A1 (en) Free ngal as a biomarker for cancer
US20090215102A1 (en) Method to Assess Breast Cancer Risk
US7858324B2 (en) Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin
US20100209944A1 (en) Adamts-7 as a biomarker for cancers of epithelial origin
US20180156808A1 (en) Methods for diagnosis and prognosis of cancers of epithelial origin
CN101346629A (zh) 评估乳癌风险的方法

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination